The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy

Methicillin-resistant Staphylococcus aureus (MRSA) is associated with substantial morbidity and mortality. Vancomycin (VAN) has been used as the gold standard treatment for invasive MRSA infections for decades but, unfortunately, the reliance of VAN as the primary treatment option against these infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrisette, Taylor, Alosaimy, Sara, Abdul-Mutakabbir, Jacinda C., Kebriaei, Razieh, Rybak, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692208/
https://www.ncbi.nlm.nih.gov/pubmed/33143290
http://dx.doi.org/10.3390/antibiotics9110762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692208/
https://www.ncbi.nlm.nih.gov/pubmed/33143290
http://dx.doi.org/10.3390/antibiotics9110762

Ejemplares similares